{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "document", "Document"], "kwargs": {"metadata": {"source": "/home/guanzhideng145/research/ip_portal/patent_kg/patents/721-US20210060002A1(Pending) not sealed.pdf"}, "page_content": "A549 host cells . Among them , 4 compounds including\n\ncells significantly inhibited EV - A71 infection , with EC50\n\nCompound # 1 , # 7 , # 9 and # 11 exhibited highest potency . As\n\nbeing around 17 uM .\n\nshown in FIG . 8B , these 4 compounds can effectively block\n\n[ 0098 ] Further , pretreatment of A549 cells with berbamine\n\nthe entry of JEV into the host cells .\n\nalso abolished lentivirus infection , as shown in FIG . 11 .\n\nAntiviral Effect Against JEV in Mice\n\n[ 0099 ] Based on the above experimental results , it has\n\nbeen demonstrated that berbamine and its analogues par\n\n[ 0093 ] The inventors determined the cytotoxicity of ber\n\nticularly berbamine are potential anti - RNA virus agents .\n\nbamine in different cell lines including A549 cells , BHK - 21\n\ncells , and RD cells . As shown in FIG.9A and Table 2 , it was\n\n1. A method of preventing or treating a subject suffering\n\nfound that berbamine has lowest cytotoxicity but highest\n\nfrom a flavivirus infection by administering an effective\n\ntherapeutic index as compared to other alkaloids ( Table 3 ) .\n\namount of berbamine or its analogue to the subject , berbam\n\nThe inventors therefore assessed the anti - JEV effects of\n\nine has a structure of Formula ( I ) :\n\nberbamine in a mouse model .\n\nMar. 4, 2021\n\nUS 2021/0060002 A1\n\n11\n\nTABLE 1-continued\n\nTABLE 2\n\nCytotoxicity of berbamine in various cell lines. Cell Type CCso (uM) Vero 114.936 = 5.297 Hela 114.762 = 3.596 A549 126.629 = 3.896 Huh? 90.436 2.977 BHK-21 126.841 = 2.426\n\nIdentified additional compounds. #9 0\n\nTABLE 3\n\nSelectivity index Virus Selective Index (CCso/ECso} ZIKV 63.3 JEV 5.7 EV71 73", "type": "Document"}}